Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium phosphate monobasic
- Development stage
- Phase 4
- Modality
- Small Molecules
- Administration
- Oral, Rectal, Intravenous, Ophthalmic
01
Overview
Sodium phosphate monobasic, also known as monosodium phosphate, is an inorganic chemical compound widely utilized in both pharmaceutical and food industries. In pharmaceutical applications, it serves multiple roles, including as a buffering agent to maintain stable pH in various formulations (oral, injectable, ophthalmic), a sequestering agent, and therapeutically as a mild saline laxative and for the treatment of hypophosphatemia. It exists in various forms, such as anhydrous, monohydrate, and dihydrate. It is also used in food products as an emulsifier, stabilizer, thickener, and pH buffer.
- Brand names
- OsmoPrepVisicolFleet Enema
- Other names
- monosodium phosphatesodium dihydrogen phosphate monohydrate
Beyond the preview
Go deeper on sodium phosphate monobasic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium phosphate monobasic.